Eckert & Ziegler SE

Equities

EUZ

DE0005659700

Office Equipment

Market Closed - Xetra 09:05:15 28/06/2024 pm IST After market 01:29:52 am
45.86 EUR -4.22% Intraday chart for Eckert & Ziegler SE 45.93 +0.15%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
German Stocks Fall Tuesday DJ
Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic MT
Announcement drives Eckert & Ziegler - shares above 21-day line DP
ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating ZD
Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Eckert & Ziegler SE, Q1 2024 Earnings Call, May 14, 2024
ECKERT & ZIEGLER : Hauck & Aufhauser maintains a Buy rating ZD
Eckert & Ziegler increases profit at the start of the year - targets confirmed DP
Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024 CI
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals CI
Transcript : Eckert & Ziegler Strahlen- und Medizintechnik AG, 2023 Earnings Call, Mar 22, 2024
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong' DP
Eckert & Ziegler cuts dividend in favor of investments DP
ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser ZD
Eckert & Ziegler plans further growth - dividend decreases significantly DP
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX Index (Price Return) CI
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX (Total Return) Index CI
Deutsche Börse's Stoxx to Make Changes to DAX Indices MT
Index changes move - MDax ejection weighs on Rational DP
ECKERT & ZIEGLER : Gets a Buy rating from Hauck & Aufhauser ZD
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177 CI
ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating ZD
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating ZD
Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm DP
Chart Eckert & Ziegler SE
More charts
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
47.88 EUR
Average target price
62.5 EUR
Spread / Average Target
+30.53%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EUZ Stock
  4. News Eckert & Ziegler SE
  5. Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic